Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lum

Showing results (321-330 of 361) with videos related to

Pageof 37
Sort By:
Journal for Immunotherapy of Cancer|January 28, 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myelomaBinod Dhakal, Parameswaran Hari, Saurabh Chhabra, et al.
Annals of Internal Medicine|December 1, 1987
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantationJ D Meyers, N Flournoy, J E Sanders, et al.
Journal for Immunotherapy of Cancer|June 12, 2021
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0-2+) metastatic breast cancerLawrence G Lum, Zaid Al-Kadhimi, Abhinav Deol, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Bone Marrow Transplantation|August 22, 2003
The marrow stem cell: the continuumP J Quesenberry, G A Colvin, M Abedi, et al.
Oncotarget|January 13, 2016
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewalPrahlad Parajuli, Rohit Anand, Chandramouli Mandalaparty, et al.
Bone Marrow Transplantation|January 20, 2015
Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohortZ Gul, E Van Meter, M Abidi, et al.
Oncogene|February 18, 2022
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancerGuilin Qiao, Lyonell B Kone, Evan H Phillips, et al.
Trials|November 2, 2018
Protocol for a randomised controlled trial of cognitive bias modification training during inpatient withdrawal from alcohol use disorderVictoria Manning, Joshua B B Garfield, Samuel C Campbell, et al.
Sexually Transmitted Infections|October 4, 2005
A cluster of culture positive gonococcal infections but with false negative cppB gene based PCRG Lum, K Freeman, N L Nguyen, et al.
Pageof 37

Showing results (321-330 of 361) with videos related to

Sort By:
Pageof 37
Journal for Immunotherapy of Cancer|January 28, 2025
Rapamycin-resistant polyclonal Th1/Tc1 cell therapy (RAPA-201) safely induces disease remissions in relapsed, refractory multiple myelomaBinod Dhakal, Parameswaran Hari, Saurabh Chhabra, et al.
Annals of Internal Medicine|December 1, 1987
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantationJ D Meyers, N Flournoy, J E Sanders, et al.
Journal for Immunotherapy of Cancer|June 12, 2021
Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0-2+) metastatic breast cancerLawrence G Lum, Zaid Al-Kadhimi, Abhinav Deol, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Bone Marrow Transplantation|August 22, 2003
The marrow stem cell: the continuumP J Quesenberry, G A Colvin, M Abedi, et al.
Oncotarget|January 13, 2016
Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewalPrahlad Parajuli, Rohit Anand, Chandramouli Mandalaparty, et al.
Bone Marrow Transplantation|January 20, 2015
Low blood lymphocyte count at 30 days post transplant predicts worse acute GVHD and survival but not relapse in a large retrospective cohortZ Gul, E Van Meter, M Abidi, et al.
Oncogene|February 18, 2022
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancerGuilin Qiao, Lyonell B Kone, Evan H Phillips, et al.
Trials|November 2, 2018
Protocol for a randomised controlled trial of cognitive bias modification training during inpatient withdrawal from alcohol use disorderVictoria Manning, Joshua B B Garfield, Samuel C Campbell, et al.
Sexually Transmitted Infections|October 4, 2005
A cluster of culture positive gonococcal infections but with false negative cppB gene based PCRG Lum, K Freeman, N L Nguyen, et al.
Pageof 37